Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients.
Mir O, Alexandre J, Coriat R, Ropert S, Boudou-Rouquette P, Bui T, Chapron J, Durand JP, Dusser D, Goldwasser F.
Mir O, et al. Among authors: goldwasser f.
Invest New Drugs. 2012 Aug;30(4):1756-60. doi: 10.1007/s10637-011-9690-9. Epub 2011 May 26.
Invest New Drugs. 2012.
PMID: 21614447